First Report Customer Care 
All time: 4.6

Latest / Last 30 Days: 5.0

523 Reviews

Credit Rating - GUARDIAN PHARMACEUTICALS CO LTD

ANALYSIS
Credit Risk Update: GUARDIAN PHARMACEUTICALS CO LTD, 4 HAWTHORNE AVENUE, NANTWICH, CHESHIRE, CW5 6HZ. The legal status is a Private Limited Company and the current status at the registry of companies is Active. The last filed accounts are dated 27 January 2023. The company was incorporated on 25 January 2016.

The accounts next due date is 25 October 2024. There are no mortgages.

The above was based on public record information as at 10 May 2024 and may not reflect the current status. Please access the current report to ascertain the current status and credit rating.
SUMMARY
Registered Number: 09966444
Date Incorporated: 25 January 2016
Date Latest Accounts: 27 January 2023
BUSINESS INFORMATION
Legal Form: Private Limited Company
Previous Names: None
Registered Number: 09966444
Annual Return: 22 March 2016
Registered Office: 4 HAWTHORNE AVENUE, NANTWICH, CHESHIRE, CW5 6HZ
SIC Code and Operations: 46460,47730
SECURED CREDITORS
Number of Mortgages 0
Satisfied Mortgages 0
Part Satisfied Mortgages 0
Unsatisfied Mortgages 0
CREDIT RISK RATING
This is the credit risk assessment used by one of the top UK credit reference agencies.
Risk Score (1-100):

GUARDIAN PHARMACEUTICALS CO LTD

Click Here

to view this information

Risk Assessment:
Credit Rating:



First Report Score: (0-10):

Financial Status Guide:
10  trafficlight Very Strong
9   Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical
Report Created On 20 May 2024 Copyright © 2024 First Report Ltd


Recent Searches

Reg No. Reg Name Status
06324300 GUARDIAN PHARMACY LIMITED Active
13202518 GUARDIAN PHYSIQUE LTD Active - Proposal to Strike off
09861095 GUARDIAN PLANNING LIMITED Dissolved
07130376 GUARDIAN PLUMBING AND HEATING LIMITED Active
11955315 GUARDIAN PLUS CARE RECRUITMENT LTD Active - Proposal to Strike off

In using this service you agree to the Terms and Conditions

© 2024 First Report Ltd